Article
Multiplex immune serum biomarker profiling in sarcoidosis and systemic sclerosis
18 Jun 2009
Abstract excerpt
Multiplex protein technology has the potential to identify biomarkers for the differentiation, classification and improved understanding of the pathogenesis of interstitial lung disease. The aim of this study was to determine whether a 30-inflammatory biomarker panel could discriminate between healthy controls, sarcoidosis and systemic sclerosis (SSc) patients independently of other clinical indicators. We also...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
